Cancer Diagnostics – Multimedia

Isolating single cells is crucial in various research fields such as rare-cell analysis, biologics discovery and stem cell research. However, the process of identifying and isolating productive single cells remains a significant challenge, partly due to resource-intensive and often ineffective techniques like limiting dilution.

To accelerate the discovery of new cancer biomarkers and new insights into the genetics of treatment-resistant tumors, it is crucial to gain a deeper understanding of the genomic and epigenomic variations in cancer.

This infographic takes a look at some of the benefits that liquid biopsies can offer and explores examples of recent developments in this field.

Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype. However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority.

According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. Furthermore, recent estimates predict that as many as one in two people could develop a form of cancer in their lifetime.

Download this listicle to discover recent examples of how single-cell analysis methods are driving forward research into cancer, aging, and drug discovery and development.

In this episode we discuss how the combination of both genetic and epigenetic information within a single DNA sample can provide key insights on the dynamic interactions that are occurring, offering significant advantages in many research areas.

In this Teach me in 10 episode we will explore how simultaneous sequencing of genetic and epigenetic bases in cfDNA allows for early cancer detection.

In this video, Dr. Charles Rosser, a board-certified urologist discusses the development of Oncuria for the early detection of bladder cancer.

Download this app note to learn how you can select 20 individual CTCs in 10 minutes, this approach can be used for DNA, RNA or proteome analysis as well as how these target cells are selected and isolated in high purity from heterogenous backgrounds.